non glp 1 weight loss meds GLP-1 drugs: Lower dose or oral pill may help sustain brain cell function and reduce fatigue for those low in B12 Found Health's GLP-1 Review: Real

NCT02970942 results [2] Among patients treated with semaglutide, those in the 0.4 mg group experienced an average weight loss of 13%, compared to 1% in the placebo group

Injectable GLP-1s like Wegovy or Zepbound are reviewed on a case-by-case, non-formulary basis

Take control of your health and start your personalized weight loss journey with GLP-1 today

- Improved glycaemic control and cardiometabolic markers (e.g., inflammatory lipids and blood pressure reported in readouts)

With a potential user base of 30 million in the United States alone, accounting for about 9% of the population, awareness and utilization of GLP-1s are increasing due to their effectiveness

So from a primary care frontline clinicians perspective, what do you wish more primary care doctors knew about GLP-1 medications